We are live on ! Find out more
TSHA icon

Taysha Gene Therapies
TSHA

51 hedge funds and large institutions have $475M invested in Taysha Gene Therapies in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $363M → $475M (+$112M)

26% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 19

11% more funds holding

Funds holding: 46 → 51 (+5)

1.36% more ownership

Funds ownership: 46.3% → 47.67% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 9

Holders
51
Holders Change
+5
Holders Change %
+10.87%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
8
Reduced
9
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.4M
3
BlackRock
BlackRock
New York
+$8.39M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.53M
5
State Street
State Street
Massachusetts
+$2.37M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$8.37M
2
Citadel Advisors
Citadel Advisors
Florida
-$4.51M
3
UBS AM
UBS AM
Illinois
-$4.48M
4
ACH
ArrowMark Colorado Holdings
Colorado
-$4.28M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$949K +$533K +24,749 +225%
Morgan Stanley
27
Morgan Stanley
New York
$832K +$675K +31,338 New
CCM
28
CAAS Capital Management
New York
$796K – – –
Bank of New York Mellon
29
Bank of New York Mellon
New York
$716K +$581K +26,980 New
JP Morgan Chase
30
JP Morgan Chase
New York
$630K +$512K +23,748 New
Millennium Management
31
Millennium Management
New York
$515K -$3.31M -153,857 -89%
CIP
32
Chartwell Investment Partners
Pennsylvania
$497K +$404K +18,737 New
Goldman Sachs
33
Goldman Sachs
New York
$392K -$1.38M -63,862 -81%
N
34
Nuveen
North Carolina
$378K +$307K +14,228 New
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$355K -$4.02M -186,634 -93%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$348K +$283K +13,128 New
Wells Fargo
37
Wells Fargo
California
$330K +$268K +12,441 New
Bank of America
38
Bank of America
North Carolina
$174K +$141K +6,556 New
Deutsche Bank
39
Deutsche Bank
Germany
$162K +$131K +6,089 New
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$130K +$106K +4,900 New
CSS
41
Cubist Systematic Strategies
Connecticut
$118K +$95.9K +4,453 New
SO
42
STRS Ohio
Ohio
$55K +$45.2K +2,100 New
Citigroup
43
Citigroup
New York
$43K +$34.8K +1,614 New
Bank of Montreal
44
Bank of Montreal
Ontario, Canada
$38K +$29.4K +1,364 New
Legal & General Group
45
Legal & General Group
United Kingdom
$24K +$302 +14 +2%
CAPTRUST Financial Advisors
46
CAPTRUST Financial Advisors
North Carolina
$19K +$7.54K +350 +95%
AIP
47
Ameritas Investment Partners
Nebraska
$19K +$15.7K +727 New
Royal Bank of Canada
48
Royal Bank of Canada
Ontario, Canada
$12K +$10.1K +469 New
TRCT
49
Tower Research Capital (TRC)
New York
$8K +$6.31K +293 New
RE
50
RBC Europe
United Kingdom
$6.63K +$5.39K +250 New
1
2
3

TSHA Hedge Fund Activity: Q4 2020 in Review

51 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Taysha Gene Therapies (TSHA) for Q4 2020, worth a combined $475M — up 31% from $363M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new TSHA positions and 19 closed out — a net gain of 5 holders — while 8 added to existing stakes and 9 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.4M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $8.37M sold.

  • 51 institutional investors held Taysha Gene Therapies (TSHA) as of Q4 2020, up from 46 in Q3 2020.
  • Funds reported $475M of Taysha Gene Therapies stock for Q4 2020, up 31% quarter-over-quarter.
  • 24 funds opened new Taysha Gene Therapies positions in Q4 2020 and 19 closed out, a net change of +5 holders.
  • The largest Taysha Gene Therapies buyer in Q4 2020 was Fidelity Investments, an estimated $31.4M added.
  • The largest Taysha Gene Therapies seller in Q4 2020 was Sectoral Asset Management, an estimated $8.37M sold.

Based on aggregated 13F filings for Q4 2020.